Lupin quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	8,277	6,268	+32.0%
EBITDA	2,450	1,727	+41.8%
EBITDA margin	29.6%	27.6%	+2.1 pts
Profit before tax	2,017	1,416	+42.5%
Net profit	1,417	1,221	+16.0%
EPS	₹30.95	₹26.70	+15.9%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	8,277	7,475	7,168	7,048	6,268	5,667	5,768	5,673	5,600	4,961	5,197	5,039	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	130	141	115	90.0	79.0	57.0	53.7	42.3	67.8	29.3	29.4	40.4
	8,407	7,615	7,282	7,138	6,347	5,724	5,821	5,715	5,668	4,990	5,227	5,079
	1,312	1,231	1,125	1,139	1,127	1,109	1,084	1,118	1,146	1,094	1,107	991
	842	708	720	725	714	576	766	660	641	661	676	855
	−64.7	−88.1	33.6	−39.3	−68.7	1.1	−129	−88.2	−41.7	−182	−56.8	−143
	1,383	1,243	1,143	1,106	1,083	1,001	984	1,008	971	900	889	861
	110	120	115	108	91.8	89.1	66.9	70.9	68.0	71.3	74.0	80.6
	453	447	313	317	299	393	271	257	248	457	257	248
	2,355	1,895	1,884	1,776	1,686	1,659	1,706	1,635	1,644	1,490	1,544	1,557
	6,390	5,556	5,334	5,131	4,932	4,828	4,750	4,660	4,675	4,492	4,491	4,449
	2,450	2,486	2,262	2,341	1,727	1,321	1,356	1,340	1,241	997	1,038	918
	1,997	2,039	1,949	2,025	1,428	928	1,084	1,083	993	540	781	670
Profit
	2,017	2,059	1,949	2,007	1,416	896	1,071	1,055	993	498	736	630
	0.0	−131	−427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	2,017	1,928	1,522	2,007	1,416	896	1,071	1,055	993	498	736	630
	984	508	205	324	491	281	269	203	238	106	226	172
	−384	−48.6	137	198	−297	−168	−56.7	−7.6	−50.1	23.5	−108	−38.0
	600	459	342	522	194	113	212	195	187	129	117	134
	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	1,417	1,469	1,181	1,485	1,221	782	859	859	806	368	619	495
	1,417	1,469	1,181	1,485	1,221	782	859	859	806	368	619	495
	35.5	64.3	120	95.8	160	23.0	−120	57.7	−52.7	−27.1	78.2	22.4
	1,452	1,533	1,301	1,581	1,382	805	739	917	753	341	697	518
	1,415	1,460	1,176	1,478	1,219	773	855	853	801	359	613	490
	2.0	8.3	5.0	6.9	2.4	9.9	3.7	6.9	4.2	8.8	5.6	5.7
Per share
	₹30.95	₹31.96	₹25.74	₹32.36	₹26.70	₹16.93	₹18.75	₹18.70	₹17.58	₹7.89	₹13.47	₹10.76
	₹30.89	₹31.89	₹25.67	₹32.28	₹26.62	₹16.87	₹18.69	₹18.64	₹17.52	₹7.86	₹13.41	₹10.72
Other comprehensive income — detail
	35.5	64.3	120	95.8	160	23.0	—	—	—	—	—	—
	−0.1	0.5	−5.9	9.4	−10.4	−17.8	16.0	−11.1	−10.5	5.1	−10.4	−1.4
	−0.1	1.9	−2.7	4.3	−3.6	−6.4	—	—	—	—	—	—
	—	—	—	—	—	—	6.0	−3.9	−3.7	0.8	−2.5	−0.5
	52.2	51.8	123	75.4	169	34.4	−130	64.9	−36.3	−30.9	86.4	22.8
	16.7	−13.9	−0.5	−15.3	2.5	0.0	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	9.6	0.5	0.3	−0.5
	1,451	1,522	1,296	1,573	1,377	795	737	907	752	334	690	513
	1.4	11.0	4.9	7.2	4.4	10.6	2.7	10.5	0.8	7.6	7.3	4.9
Per share — as-filed variants
	₹30.95	₹31.96	₹25.74	₹32.36	₹26.70	₹16.93	₹18.75	₹18.70	₹17.58	₹7.89	₹13.47	₹10.76
	₹30.89	₹31.89	₹25.67	₹32.28	₹26.62	₹16.87	₹18.69	₹18.64	₹17.52	₹7.86	₹13.41	₹10.72
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	6,188	5,623	5,289	5,223	4,496	3,981	4,046	3,983	3,856	3,387	3,471	3,336
	74.8%	75.2%	73.8%	74.1%	71.7%	70.2%	70.2%	70.2%	68.8%	68.3%	66.8%	66.2%
Adjusted (ex-exceptional items) — derived
	2,017	2,059	1,949	2,007	1,416	896	1,071	1,055	993	498	736	630
	0.0	−131	−427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	1,417	1,569	1,511	1,485	1,221	782	859	859	806	368	619	495
	₹30.95	₹34.14	₹32.95	₹32.36	₹26.70	₹16.93	₹18.75	₹18.70	₹17.58	₹7.89	₹13.47	₹10.76

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersSUNPHARMA CIPLA DRREDDY ALKEM FORTIS AUROPHARMA LAURUSLABS MANKINDMcap ₹90,192 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	5,038.6	5,197.4	4,960.8	5,600.3	5,672.7	5,767.7	5,667.1	6,268.3	7,047.5	7,167.5	7,474.7	8,276.9
Other Income	40.4	29.4	29.3	67.8	42.3	53.7	57.0	79.0	90.0	114.7	140.7	130.3
Total Income	5,079.0	5,226.8	4,990.0	5,668.1	5,715.0	5,821.4	5,724.1	6,347.4	7,137.5	7,282.2	7,615.4	8,407.2
Expenses
+ Cost of Materials Consumed	991.0	1,106.7	1,094.4	1,145.7	1,118.1	1,084.1	1,109.5	1,126.6	1,139.2	1,124.8	1,231.3	1,311.7
+ Purchases of Stock-in-Trade	854.7	676.1	661.1	640.6	660.0	766.4	575.7	714.0	724.9	719.7	708.4	842.3
+ Changes in Inventories	-143.0	-56.8	-181.7	-41.7	-88.2	-128.9	1.1	-68.7	-39.3	33.6	-88.1	-64.7
+ Employee Benefit Expense	860.7	889.2	900.2	971.0	1,007.5	984.4	1,001.3	1,083.0	1,105.6	1,143.3	1,242.7	1,383.0
+ Finance Costs	80.6	74.0	71.3	68.0	70.9	66.9	89.1	91.8	107.6	115.0	120.2	109.6
+ Depreciation & Amortisation	247.9	257.2	457.1	247.7	256.9	271.5	393.2	299.0	316.8	313.0	446.8	452.9
+ Other Expenses	1,557.3	1,544.2	1,489.9	1,643.8	1,634.9	1,705.9	1,658.5	1,686.2	1,775.9	1,884.3	1,894.8	2,355.1
Total Expenses	4,449.3	4,490.7	4,492.3	4,675.1	4,660.2	4,750.2	4,828.2	4,931.8	5,130.5	5,333.6	5,556.0	6,389.8
EBITDA	917.8	1,037.9	996.9	1,241.0	1,340.4	1,355.9	1,321.2	1,727.2	2,341.3	2,261.9	2,485.6	2,449.6
EBIT	669.9	780.7	539.8	993.3	1,083.4	1,084.5	928.0	1,428.3	2,024.6	1,948.9	2,038.8	1,996.7
Profit
PBT before Exceptional Items	629.7	736.1	497.7	993.0	1,054.9	1,071.3	895.8	1,415.5	2,007.0	1,948.6	2,059.3	2,017.4
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-426.6	-131.3	0.0
Pretax Income	629.7	736.1	497.7	993.0	1,054.9	1,071.3	895.8	1,415.5	2,007.0	1,522.0	1,928.0	2,017.4
+ Current Tax	172.3	225.5	106.0	237.6	202.9	269.1	281.1	490.9	324.0	204.6	507.9	984.4
+ Deferred Tax	-38.0	-108.1	23.5	-50.1	-7.6	-56.7	-167.7	-296.8	198.2	137.0	-48.6	-384.0
Tax Expense	134.4	117.4	129.5	187.5	195.4	212.4	113.5	194.1	522.1	341.5	459.3	600.4
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.0
Net Income	495.3	618.7	368.2	805.5	859.5	858.9	782.4	1,221.5	1,484.8	1,180.5	1,468.7	1,417.0
+ Net Income — Continuing Ops	495.3	618.7	368.2	805.5	859.5	858.9	782.4	1,221.5	1,484.8	1,180.5	1,468.7	1,417.0
+ Other Comprehensive Income	22.4	78.2	-27.1	-52.7	57.7	-119.5	23.0	160.2	95.8	120.1	64.3	35.5
Total Comprehensive Income	517.7	696.9	341.1	752.9	917.2	739.3	805.4	1,381.7	1,580.7	1,300.6	1,532.9	1,452.5
Net Income to Common	489.7	613.1	359.4	801.3	852.6	855.2	772.5	1,219.0	1,477.9	1,175.6	1,460.3	1,415.0
Minority Interest	5.7	5.6	8.8	4.2	6.9	3.7	9.9	2.4	6.9	5.0	8.3	2.0
Per Share
Basic EPS	10.76	13.47	7.89	17.58	18.70	18.75	16.93	26.70	32.36	25.74	31.96	30.95
Diluted EPS	10.72	13.41	7.86	17.52	18.64	18.69	16.87	26.62	32.28	25.67	31.89	30.89
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	23.0	160.2	95.8	120.1	64.3	35.5
+ Items NOT to be Reclassified to P&L	-1.4	-10.4	5.1	-10.5	-11.1	16.0	-17.8	-10.4	9.4	-5.9	0.5	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-6.4	-3.6	4.3	-2.7	1.9	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.5	-2.5	0.8	-3.7	-3.9	6.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	22.8	86.4	-30.9	-36.3	64.9	-129.5	34.4	169.5	75.4	122.9	51.8	52.2
+ Tax on Items to be Reclassified	—	—	—	—	—	—	0.0	2.5	-15.3	-0.5	-13.9	16.7
+ Tax on Items to be Reclassified — alt tag	-0.5	0.3	0.5	9.6	0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	512.8	689.6	333.5	752.1	906.6	736.6	794.9	1,377.3	1,573.5	1,295.7	1,522.0	1,451.1
Comprehensive Income — Non-controlling Interests	4.9	7.3	7.6	0.8	10.5	2.7	10.6	4.4	7.2	4.9	11.0	1.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	10.76	13.47	7.89	17.58	18.70	18.75	16.93	26.70	32.36	25.74	31.96	30.95
Diluted EPS — Continuing Operations	10.72	13.41	7.86	17.52	18.64	18.69	16.87	26.62	32.28	25.67	31.89	30.89
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	3,335.8	3,471.3	3,387.0	3,855.8	3,982.8	4,046.2	3,980.9	4,496.4	5,222.7	5,289.4	5,623.0	6,187.7
Gross Margin %	66.21	66.79	68.27	68.85	70.21	70.15	70.25	71.73	74.11	73.80	75.23	74.76
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	629.7	736.1	497.7	993.0	1,054.9	1,071.3	895.8	1,415.5	2,007.0	1,948.6	2,059.3	2,017.4
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-426.6	-131.3	0.0
Net Income Adj (tax-effected)	495.3	618.7	368.2	805.5	859.5	858.9	782.4	1,221.5	1,484.8	1,511.4	1,568.7	1,417.0
EPS Adj	10.76	13.47	7.89	17.58	18.70	18.75	16.93	26.70	32.36	32.95	34.14	30.95
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	91.1	91.1	91.1	91.2	91.2	91.3	91.3	91.4	91.4	91.4	91.4	91.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Lupin Q2 FY27 results date

Lupin (NSE: LUPIN) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 19 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit attributable to shareholders was ₹1,415 crore, up 16.1% from ₹1,219 crore in Q1 FY26 and down 3.1% from ₹1,460 crore in Q4 FY26. Revenue from operations was ₹8,277 crore, up 32.0% year on year and up 10.7% from the previous quarter.

Board-meeting notice filed: 19 October 2026
Q2 FY26 results (a year earlier): 6 November 2025
Q1 FY27 results (the latest): 6 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 19 Oct
Q1 FY27 net profit: ₹1,415 Cr+16.1% vs Q1 FY26−3.1% vs Q4 FY26
Q1 FY27 revenue: ₹8,277 Cr+32.0% vs Q1 FY26+10.7% vs Q4 FY26
Q1 FY27 operating margin: 24.1%+1.3 pts vs Q1 FY26−3.2 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹1,478 CrRevenue ₹7,048 Cr
Q1 FY27 EPS (basic): ₹30.95

Questions

When will Lupin announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 19 October 2026). Last year it reported Q2 FY26 on 6 November 2025.

What were Lupin's Q1 FY27 results?

Consolidated net profit attributable to shareholders was ₹1,415 crore, up 16.1% from ₹1,219 crore in Q1 FY26 and down 3.1% from ₹1,460 crore in Q4 FY26. Revenue from operations was ₹8,277 crore, up 32.0% year on year and up 10.7% from the previous quarter.

What was Lupin's revenue in FY26?

Revenue from operations was ₹27,958 crore in FY26 (April 2025–March 2026), up 23.1% from ₹22,708 crore in FY25. It was ₹20,011 crore in FY24 and ₹16,642 crore in FY23: up 68.0% over three years, 18.9% a year on average.

What will Lupin's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit attributable to shareholders was ₹1,478 crore and revenue from operations ₹7,048 crore. The latest quarter, Q1 FY27, had a net profit of ₹1,415 crore and revenue of ₹8,277 crore.

How has Lupin's profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹1,478 crore in Q2 FY26, ₹1,176 crore in Q3 FY26, ₹1,460 crore in Q4 FY26 and ₹1,415 crore in Q1 FY27. That is ₹5,529 crore over the four quarters, up 49.5% from ₹3,699 crore in the four quarters before. Revenue from operations: ₹7,048 crore, ₹7,168 crore, ₹7,475 crore and ₹8,277 crore.

What was Lupin's net profit in FY26?

Consolidated net profit attributable to shareholders was ₹5,333 crore in FY26 (April 2025–March 2026), up 62.5% from ₹3,282 crore in FY25. It was ₹1,914 crore in FY24 and ₹430 crore in FY23: up 1,140.0% over three years, 131.5% a year on average.

Where do these Lupin figures come from?

From Lupin's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.